Search Results - "Pickar, James H"

Refine Results
  1. 1
  2. 2

    Back to the future: Hormone replacement therapy as part of a prevention strategy for women at the onset of menopause by Lobo, Roger A, Pickar, J.H, Stevenson, J.C, Mack, W.J, Hodis, H.N

    Published in Atherosclerosis (01-11-2016)
    “…Abstract In the late 1980s, several observational studies and meta-analyses suggested that hormone replacement therapy (HRT) was beneficial for prevention of…”
    Get full text
    Journal Article
  3. 3

    Endometrial effects of a tissue selective estrogen complex containing bazedoxifene/conjugated estrogens as a menopausal therapy by Pickar, James H., M.D, Yeh, I-Tien, M.D, Bachmann, Gloria, M.D, Speroff, Leon, M.D

    Published in Fertility and sterility (01-09-2009)
    “…Objective To evaluate the endometrial safety of a tissue selective estrogen complex (TSEC; pairing of a selective estrogen receptor modulator [SERM] with…”
    Get full text
    Journal Article
  4. 4

    Efficacy of tissue-selective estrogen complex of bazedoxifene/conjugated estrogens for osteoporosis prevention in at-risk postmenopausal women by Lindsay, Robert, Ph.D, Gallagher, J. Christopher, M.D, Kagan, Risa, M.D, Pickar, James H., M.D, Constantine, Ginger, M.D

    Published in Fertility and sterility (01-09-2009)
    “…Objective To evaluate the efficacy of the tissue-selective estrogen complex, bazedoxifene/conjugated estrogens (BZA/CE), for postmenopausal osteoporosis…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Bazedoxifene/conjugated estrogens (BZA/CE): incidence of uterine bleeding in postmenopausal women by Archer, David F., M.D, Lewis, Vivian, M.D, Carr, Bruce R., M.D, Olivier, Sophie, M.D, Pickar, James H., M.D

    Published in Fertility and sterility (01-09-2009)
    “…Objective To evaluate the effect of bazedoxifene/conjugated estrogens (BZA/CE), a tissue selective estrogen complex, on uterine bleeding in postmenopausal…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Desvenlafaxine for the treatment of vasomotor symptoms associated with menopause: a double-blind, randomized, placebo-controlled trial of efficacy and safety by Archer, David F., MD, Dupont, Caroline M., MD, Constantine, Ginger D., MD, Pickar, James H., MD, Olivier, Sophie, MD

    “…Objective The objective of the study was to assess the efficacy and safety of desvenlafaxine (administered as desvenlafaxine succinate) for the treatment of…”
    Get full text
    Journal Article
  9. 9

    Tissue selective estrogen complex (TSEC): a review by Pickar, James H, Boucher, Matthieu, Morgenstern, Diana

    Published in Menopause (New York, N.Y.) (01-09-2018)
    “…OBJECTIVE:This review describes historical development of selective estrogen receptor modulators (SERMs) and their combination with estrogens, termed a tissue…”
    Get full text
    Journal Article
  10. 10

    Selective estrogen receptor modulators (SERMs): A review of clinical data by Mirkin, Sebastian, Pickar, James H

    Published in Maturitas (01-01-2015)
    “…Abstract SERMs represent a diverse group of molecules with varying levels of estrogenic agonist and antagonist activity in target tissues. SERMs have a long…”
    Get full text
    Journal Article
  11. 11

    Endometrial effects of bazedoxifene acetate, a novel selective estrogen receptor modulator, in postmenopausal women by RONKIN, Sheila, NORTHINGTON, Robert, BARACAT, Edmund, NUNES, Marcia G, ARCHER, David F, CONSTANTINE, Ginger, PICKAR, James H

    Published in Obstetrics and gynecology (New York. 1953) (01-06-2005)
    “…To assess the endometrial effects of bazedoxifene acetate in healthy postmenopausal women. The endometrial effects of bazedoxifene 2.5, 5.0, 10, 20, 30, and 40…”
    Get full text
    Journal Article
  12. 12

    Patient considerations in the management of menopausal symptoms: role of conjugated estrogens with bazedoxifene by Kagan, Risa, Goldstein, Steven R, Pickar, James H, Komm, Barry S

    Published in Therapeutics and clinical risk management (01-01-2016)
    “…Menopausal symptoms (eg, hot flushes and vaginal symptoms) are common, often bothersome, and can adversely impact women's sexual functioning, relationships,…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16

    Molecular clustering of endometrial carcinoma based on estrogen-induced gene expression by Westin, Shannon N., Broaddus, Russell R., Deng, Lei, McCampbell, Adrienne, Lu, Karen H., Lacour, Robin A., Milam, Michael R., Urbauer, Diana L., Mueller, Peter, Pickar, James H., Loose, David S.

    Published in Cancer biology & therapy (15-11-2009)
    “…Identification of biomarkers potentially provides prognostic information that can help guide clinical decision-making.  Given the relationship between estrogen…”
    Get full text
    Journal Article
  17. 17

    Body composition during treatment with conjugated estrogens with and without medroxyprogesterone acetate: analysis of the women’s Health, Osteoporosis, Progestin, Estrogen (HOPE) trial by Thorneycroft, Ian H., MD, PhD, Lindsay, Robert, MBChB, PhD, Pickar, James H., MD

    “…Objective The objective of the study was to determine the effects of several doses of conjugated estrogens (CE) and CE plus medroxyprogesterone acetate (MPA)…”
    Get full text
    Journal Article
  18. 18

    SERMs: Progress and future perspectives by Pickar, James H, MacNeil, Tanya, Ohleth, Kathleen

    Published in Maturitas (01-10-2010)
    “…Abstract Selective estrogen receptor modulators (SERMs) interact with estrogen receptors as agonists or antagonists depending on the target tissue. Currently…”
    Get full text
    Journal Article
  19. 19
  20. 20